Rapid anaemia control with epoetin: results of a Swiss survey on treatment of chemotherapy-induced anaemia.

摘要

Cancer-related anaemia is common. Its aetiology is multifactorial, with chemotherapy being the single most common causal factor [1]. The European Cancer Anae mia Survey reported an analysis of 15,367 patients from across 24 European countries who were evaluated for up to 6 months [2]. The prevalence of anaemia (<12 g/dl) during follow-up was 68% in the total cohort (51-81% across tumour types) as compared to 75% (62-88%) in those receiving chemotherapy and 40% (27-52%) in those receiving no treatment. Overall, 39% of patients received treatment for their anaemia, most frequently with epoe-tin alone or in combination with iron supplementation and/or RBC transfusion (17%). These findings confirm the particular clinical impact of chemotherapy-induced anaemia in this population.